Novartis sues Apotex at New Jersey court to protect Zometa

02-06-2015

Novartis sues Apotex at New Jersey court to protect Zometa

lucarista / Shutterstock.com

Novartis has sued Apotex at the US District Court for the District of New Jersey to protect its drug Zometa (zoledronic acid) from generic competition.


Novartis, Apotex, Zometa, ANDA, US District Court for the District of New Jersey

LSIPR